ESMO 2022 | Management of locally advanced HNSCC with IO

Jean-Pascal Machiels, MD, PhD, Cliniques Universitaires Saint-Luc, Brussels, Belgium, discusses the need for improved selection of patients with head and neck cancer for immunotherapy, leading to better personalisation of treatment. Dr Machiels also discusses current research into adjuvant treatment for these patients. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.